JW (Cayman) Therapeutics Co. Ltd

HKEX:2126.HK

1.42 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018
Operating Activities:
Net Income -767.996-846.135-702.328-1,663.803-633.257-272.616
Depreciation & Amortization 99.83481.36646.32723.16817.0585.109
Deferred Income Tax 0-68.44-60.586-133.2953.4320
Stock Based Compensation 34.96582.50289.37134.2515.4430
Change In Working Capital 3.188-14.062-28.784-0.955-18.875-0.195
Accounts Receivables 5.305-5.3050000
Inventory 5.381-8.757-28.784-0.95500
Accounts Payables 011.0330000
Other Working Capital -7.498-11.03378.56917.626-18.875-0.195
Other Non Cash Items -21.611228.04794.8031,379.63427.276161.476
Operating Cash Flow -398.418-536.722-561.198-261.005-188.923-106.226
Investing Activities:
Investments In Property Plant And Equipment -14.58-76.874-73.087-124.238-101.946-44.148
Acquisitions Net 00045.30800
Purchases Of Investments 0-23.5520000
Sales Maturities Of Investments 000000
Other Investing Activites 22.313-23.657-64.043-12.979-15.608-0.501
Investing Cash Flow 9.904-124.083-137.13-91.909-117.554-44.148
Financing Activities:
Debt Repayment 000000
Common Stock Issued 0.0270.0940.6972,140.20900
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities -12.388228.013-18.298731.013459.346252.468
Financing Cash Flow 0.275112.354-30.6212,859.427414.049249.825
Other Information:
Effect Of Forex Changes On Cash 10.81297.388-67.25-130.78113.63113.01
Net Change In Cash -377.427-451.063-796.1992,375.732121.203112.461
Cash At End Of Period 1,005.9091,383.3361,834.3992,630.598254.866133.663